SELICK HAROLD E 4
4 · Protagonist Therapeutics, Inc · Filed Mar 11, 2024
Insider Transaction Report
Form 4
SELICK HAROLD E
Director
Transactions
- Exercise/Conversion
Common Stock
2024-03-07$1.89/sh+6,490$12,266→ 27,996 total - Exercise/Conversion
Stock Option (right to buy)
2024-03-07−6,490→ 0 totalExercise: $1.89Exp: 2024-10-22→ Common Stock (6,490 underlying)
Footnotes (1)
- [F1]The stock option is fully vested.